These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Hughes T; Briercheck EL; Freud AG; Trotta R; McClory S; Scoville SD; Keller K; Deng Y; Cole J; Harrison N; Mao C; Zhang J; Benson DM; Yu J; Caligiuri MA Cell Rep; 2014 Jul; 8(1):150-62. PubMed ID: 24953655 [TBL] [Abstract][Full Text] [Related]
5. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. Male V; Hughes T; McClory S; Colucci F; Caligiuri MA; Moffett A J Immunol; 2010 Oct; 185(7):3913-8. PubMed ID: 20802153 [TBL] [Abstract][Full Text] [Related]
6. Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Tang Q; Ahn YO; Southern P; Blazar BR; Miller JS; Verneris MR Blood; 2011 Apr; 117(15):4052-5. PubMed ID: 21310921 [TBL] [Abstract][Full Text] [Related]
7. Effects of interleukin-15 on human CD3(-)CD117(+)CD56(-)OX40L(+) cell differentiation. Kim S; Han S; Kim MY Hum Immunol; 2010 Aug; 71(8):745-50. PubMed ID: 20510321 [TBL] [Abstract][Full Text] [Related]
8. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Cella M; Fuchs A; Vermi W; Facchetti F; Otero K; Lennerz JK; Doherty JM; Mills JC; Colonna M Nature; 2009 Feb; 457(7230):722-5. PubMed ID: 18978771 [TBL] [Abstract][Full Text] [Related]
9. Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells. Ahn YO; Blazar BR; Miller JS; Verneris MR Blood; 2013 Mar; 121(12):2234-43. PubMed ID: 23327921 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Colonna M Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
12. Cytokine requirements for the growth and development of mouse NK cells in vitro. Toomey JA; Gays F; Foster D; Brooks CG J Leukoc Biol; 2003 Aug; 74(2):233-42. PubMed ID: 12885940 [TBL] [Abstract][Full Text] [Related]
13. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Cella M; Otero K; Colonna M Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10961-6. PubMed ID: 20534450 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929 [TBL] [Abstract][Full Text] [Related]
15. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood. Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068 [TBL] [Abstract][Full Text] [Related]
16. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Montaldo E; Vitale C; Cottalasso F; Conte R; Glatzer T; Ambrosini P; Moretta L; Mingari MC Blood; 2012 Apr; 119(17):3987-96. PubMed ID: 22403260 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells, macrophages, NK and CD8 Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752 [TBL] [Abstract][Full Text] [Related]
18. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells. Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284 [TBL] [Abstract][Full Text] [Related]
20. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]